Top industry experts weigh in on what the new year holds for the pharma industry.
David Ehrlich
Advertisement
Articles by David Ehrlich
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
2
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
3
Uncertainty Surrounding Pharma Tariff Deadlines
4
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
5